In 2021, Wu SZ et al. [56] developed an intrinsic typing method (scSubtype) based on the scRNA-seq results of 26 patients with primary breast cancer (11 ER + , 5 HER2 + , and 10 TNBC). This evidence concerns the gene ERBB2 and breast carcinoma.